An experimental treatment developed from cattle plasma for Middle East respiratory syndrome (MERS) coronavirus infection shows broad potential, according to a small clinical trial. The treatment, SAB-301, was safe and well tolerated by healthy volunteers, with only minor reactions documented.

Get the Boer Goat Profits Guide Power Pack

How To DIY Aquaponics System



Source link

LIKE TO GET ALERT ON LATEST AGRIBUSINESS NEWS & OPPORTUNITIES? CLICK TO DOWNLOAD THE AGRICULTURAL BUSINESS ANDROID APP ON GOOGLE PLAY

Share: